Drawing for TREEFROG THERAPEUTICS

USPTO serial 79273327

TREEFROG THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 6213500Status 700Renewal
Filing date
Status date
Registration date
Dec 8, 2020
Examiner
HUSSAIN, TASNEEM
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TREEFROG THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Denys

Todd A. Denys Porzio, Bromberg & Newman, P.C.600 Alexander Road, Suite 2-1Princeton, NJ 08540UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research; stem cells for scientific purposes; nutrition agents, namely, cell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical purposesACTIVE—
005Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns; stem cells for medical or veterinary use; pluripotent stem cells for medical purposes intended for cell and gene therapies; cell culture media for cultivating human cells for medical or veterinary use; surgical implants comprised of living tissues obtained from stem cellsACTIVE—
009Scientific apparatus, namely, cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; scientific apparatus, namely, laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus, namely, microscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory use, namely, cell culture dishes and tissue culture flaks; downloadable software used for the collection, analysis, sorting, communication of biological information relating to stem cellsACTIVE—
010Apparatus for the regeneration of stem cells for medical use; apparatus for cell culture systems for medical purposes, namely, cell culture chambers and capsules; apparatus for cell culture systems by encapsulation for medical purposes, namely, cell culture chambers and capsules; apparatus for analyzing and sorting cell culture for medical purposes, namely, cell culture chambers and capsulesACTIVE—
042Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing informations with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 24, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 16, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 15, 2021FIMPFINAL DISPOSITION PROCESSED—
Mar 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 17, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 6, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Aug 6, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 6, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 6, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 28, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 28, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 8, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 8, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2020DOCKASSIGNED TO EXAMINER—
Dec 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance